Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
29 hedge funds and large institutions have $11.3M invested in Entasis Therapeutics Holdings Inc. in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 0 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
27% more capital invested
Capital invested by funds: $8.89M → $11.3M (+$2.43M)
21% more funds holding
Funds holding: 24 → 29 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$179K |
| 2 |
Jane Street
New York
|
+$87.3K |
| 3 |
VF
Virtu Financial
New York
|
+$85.8K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$70.7K |
| 5 |
Two Sigma Investments
New York
|
+$59.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$214K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$176K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$30.6K |
| 4 |
BlackRock
New York
|
-$16.7K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$2.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $5K | +$106 | +39 | +2% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | +$2.71K | +1,000 | New |
|
28
Fidelity Investments
Boston,
Massachusetts
| $1K | +$1.08K | +399 | +39,900% |
|
ETTX Hedge Fund Activity: Q3 2021 in Review
29 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q3 2021, worth a combined $11.3M — up 27% from $8.89M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ETTX positions and 0 closed out — a net gain of 5 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $179K. The largest seller was Renaissance Technologies, cutting an estimated $214K.
- 29 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q3 2021, up from 24 in Q2 2021.
- Funds reported $11.3M of Entasis Therapeutics Holdings Inc. stock for Q3 2021, up 27% quarter-over-quarter.
- 5 funds opened new Entasis Therapeutics Holdings Inc. positions in Q3 2021 and 0 closed out, a net change of +5 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q3 2021 was Two Sigma Advisers, an estimated $179K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q3 2021 was Renaissance Technologies, an estimated $214K sold.
Based on aggregated 13F filings for Q3 2021.